Latest stories on CBLL
BTIG reiterates Ceribell stock rating at buy, $30 price target
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell management to meet with BTIG
The Fly55 · neutralgeneral
Raymond James raises Ceribell stock price target on new growth drivers
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell price target raised to $30 from $28 at BTIG
The Fly61 · neutralanalyst
BTIG raises Ceribell stock price target to $30 on growth outlook
Investing.com Analyst Ratings61 · neutralanalyst
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
Yahoo Finance63 · neutralproduct/pr
Ceribell’s Revenue Jumps 33% on Strong Account Growth and Robust Margins—Financial Outlook Raised for 2026
August 11, 2026
MarketChameleon73 · bullishearnings
Canaccord raises Ceribell stock price target on strong Q2 results
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell Price Target Raised To 26 From 25 At Canaccord
The Fly56 · neutralanalyst
Ceribell expects $114M-$117M 2026 revenue as CMS finalizes delirium NTAP up to $2,171 per patient
Seeking Alpha73 · bullishearnings
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
CeriBell (CBLL) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Ceribell Raises Fy26 Revenue View To 114m 117m From 112m 116m
The Fly63 · neutralearnings
Ceribell Reports Q2 Eps 51c Consensus 46c
The Fly63 · neutralearnings
Ceribell, Inc. (CBLL) files 8-K
SEC 8-K50 · neutralgeneral
Ceribell Reports Second Quarter 2026 Financial Results
StockTitan59 · neutralearnings
Ceribell announces FDA clearance for two new AI algorithm enhancements
The Fly67 · bullishproduct/pr
CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System
InvestorsHub67 · bullishgeneral
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Business Insider73 · bullishproduct/pr
Ceribell, Inc. (CBLL) files 8-K
SEC 8-K50 · neutralgeneral
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
Business Insider55 · neutralgeneral
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
Business Insider55 · neutralgeneral
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
Business Insider50 · neutralgeneral
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
Yahoo Finance57 · neutralanalyst